Skip Navigation

A Phase 1/2 Study of M3814 Peposertib in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04172532

Study #:
STUDY00146185

Start Date:
Dec 15, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04172532

View Complete Trial Details & Eligibility at ClinicalTrials.gov